Latest 454 Life Sciences Stories
Smoking is a well-known risk factor for lung cancer, but about 25% of all lung cancer patients have never smoked. According to this study, a gene fusion event could explain a significant proportion of these lung cancer cases, and may serve as a target for new therapies.
BRANFORD, Connecticut, June 15, 2011 /PRNewswire/ -- The deadly E.
OMAHA, Neb., April 1, 2011 /PRNewswire/ -- Transgenomic, Inc. (OTC/BB: TBIO) announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker(TM)-Sequencing.
OMAHA, Neb., March 29, 2011 /PRNewswire/ -- Transgenomic, Inc.
HOUSTON, Jan. 11, 2011 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, continues to make significant strides to position itself as the Next-Generation Sequencing Provider of choice for 2011.
- The parings of haberdine; also, any kind of fragments.